Patient Experience with Dysautonomia: Physiological Perspectives and Its Impact on Quality of Life
Main Article Content
Abstract
Dysautonomia is a disorder of the autonomic nervous system that disrupts essential physiological functions, such as heart rate regulation, blood pressure control, and thermoregulation. While existing research has explored the physiological mechanisms of this condition, the subjective experiences of individuals living with dysautonomia remain underexplored, particularly regarding the diagnostic process, daily coping strategies, and social implications. The lack of qualitative research limits our understanding of how patients navigate their condition, leading to gaps in patient-centered care and medical recognition of dysautonomia as a disabling illness. This study employs Interpretative Phenomenological Analysis (IPA) to examine the lived experiences of individuals diagnosed with dysautonomia, offering a deeper understanding of their challenges and adaptation strategies. Using semi-structured interviews with ten participants, the study identifies key themes, including diagnostic uncertainty, daily functional limitations, personal coping mechanisms, and the role of social and medical support. Findings reveal that many patients face prolonged diagnostic delays, develop self-management strategies, and rely on online communities for emotional validation and medical guidance. These insights underscore the necessity of improving physician awareness, developing multidisciplinary treatment approaches, and fostering supportive networks for dysautonomia patients. The study contributes to a more holistic understanding of autonomic dysfunction and highlights the need for further research on the intersection of medical recognition, patient advocacy, and social adaptation.
Article Details
Section
References
Bhoopalan, S. V., Suryaprakash, S., Sharma, A., & Wlodarski, M. W. (2023). Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: State of the art and science. Frontiers in Oncology, 13. Scopus. https://doi.org/10.3389/fonc.2023.1236038
Compton, D. R., DeMarco, S. J., & Yalamanchili, P. (2023). AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration. International Journal of Toxicology, 42(2), 135–145. Scopus. https://doi.org/10.1177/10915818221144424
Dimitriu, C., Martignoni, M. E., Bachmann, J., Fröhlich, B., Tintarescu, G., Buliga, T., Lica, I., Constantinescu, G., Beuran, M., & Friess, H. (2005). Clinical impact of cachexia on survival and outcome of cancer patients. Romanian journal of internal medicine = Revue roumaine de médecine interne, 43(3–4), 173–185. Scopus.
Douglas, M. R. (2013). Gene therapy for Parkinson’s disease: State-of-the-art treatments for neurodegenerative disease. Expert Review of Neurotherapeutics, 13(6), 695–705. Scopus. https://doi.org/10.1586/ern.13.58
Franchini, M. (2014). Current management of hemophilia B: Recommendations, complications and emerging issues. Expert Review of Hematology, 7(5), 573–581. Scopus. https://doi.org/10.1586/17474086.2014.947955
He, Z., Li, Y., Zhao, X., & Li, B. (2022). Dravet syndrome: Advances in etiology, clinical presentation, and treatment. Epilepsy Research, 188. Scopus. https://doi.org/10.1016/j.eplepsyres.2022.107041
Himmelreich, N., Montioli, R., Bertoldi, M., Carducci, C., Leuzzi, V., Gemperle, C., Berner, T., Hyland, K., Thöny, B., Hoffmann, G. F., Voltattorni, C. B., & Blau, N. (2019). Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook. Molecular Genetics and Metabolism, 127(1), 12–22. Scopus. https://doi.org/10.1016/j.ymgme.2019.03.009
Lacy, G. D., Abalem, M. F., Musch, D. C., & Jayasundera, K. T. (2020). Patient-reported outcome measures in inherited retinal degeneration gene therapy trials. Ophthalmic Genetics, 41(1), 1–6. Scopus. https://doi.org/10.1080/13816810.2020.1731836
Nguyen, Q. M., Dupré, P.-F., Haute, T., Montier, T., & d’Arbonneau, F. (2023). Suicide gene strategies applied in ovarian cancer studies. Cancer Gene Therapy, 30(6), 812–821. Scopus. https://doi.org/10.1038/s41417-023-00590-6
Sinn, P. L., Anthony, R. M., & McCray Jr., P. B. (2011). Genetic therapies for cystic fibrosis lung disease. Human Molecular Genetics, 20, R79–R86. Scopus. https://doi.org/10.1093/hmg/ddr104
Szöőr, Á., Szöllősi, J., & Vereb, G. (2021). From antibodies to living drugs: Quo vadis cancer immunotherapy? Biologia Futura, 72(1), 85–99. Scopus. https://doi.org/10.1007/s42977-021-00072-6
Wilton-Clark, H., & Yokota, T. (2022). Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot. Genes, 13(2). Scopus. https://doi.org/10.3390/genes13020257
Worth, A. J., & Thrasher, A. J. (2015). Current and emerging treatment options for Wiskott-Aldrich syndrome. Expert Review of Clinical Immunology, 11(9), 1015–1032. Scopus. https://doi.org/10.1586/1744666X.2015.1062366